Hemogenyx Pharmaceuticals (LSE:HEMO) Buildings And Improvements : £0.70 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Buildings And Improvements?

Hemogenyx Pharmaceuticals's quarterly buildings and improvements declined from Dec. 2023 (£0.69 Mil) to Jun. 2024 (£0.00 Mil) but then increased from Jun. 2024 (£0.00 Mil) to Dec. 2024 (£0.70 Mil).

Hemogenyx Pharmaceuticals's annual buildings and improvements declined from Dec. 2022 (£0.72 Mil) to Dec. 2023 (£0.69 Mil) but then increased from Dec. 2023 (£0.69 Mil) to Dec. 2024 (£0.70 Mil).

Hemogenyx Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals Buildings And Improvements Chart

Hemogenyx Pharmaceuticals Annual Data

Trend

Feb15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

0.64

0.72

0.69

0.70

Hemogenyx Pharmaceuticals Semi-Annual Data
	Feb15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial														0.72	-	0.69	-	0.70

Hemogenyx Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Hemogenyx Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.hemogenyx.com

Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of innovative treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments.

Hemogenyx Pharmaceuticals Headlines

No Headlines